ALECTOR INC (ALEC:NASDAQ)
$2.1 0.27 (14.7541%)
Analysed ALECTOR INC (ALEC:NASDAQ) News Sources
Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases
05-10-2026
yahoo.com
Optogenetics researchers win a Nobel Prize; Roche bets on Alector brain drug
05-10-2026
biopharmadive.com
Alector Signs $1.27 Billion Genentech License Agreement for Parkinson’s Disease Program
05-10-2026
advfn.com
Alector shares up after sealing $1.27bn Roche Parkinson’s disease license deal
06-10-2026
pharmaceutical-technology.com
Alector to Host Virtual Research and Development Event Highlighting Wholly Owned Alector Brain Carrier (ABC)- Enabled Pipeline
07-10-2026
yahoo.com
Stocktwits Biotech Dealmaker — Viatris And GE Healthcare Buy What They Can Sell; Biohaven And Alector Sell Rights
10-10-2026
stocktwits.com
Alector Maps Brain-Delivery Pipeline for Alzheimer’s, Parkinson’s Therapies
13-10-2026
marketbeat.com
Alector (ALEC) Stock Fair Value Rises After Genentech Deal Draws Split Analyst Views
16-10-2026
yahoo.com
Alector Announces Pricing of Underwritten Offering
16-10-2026
yahoo.com
Alector stock surges 13% on premium-priced equity offering
16-10-2026
yahoo.com
What is the current price of ALECTOR INC (ALEC:NASDAQ)?
The current price of ALECTOR INC (ALEC:NASDAQ) is $2.1.
ALECTOR INC (ALEC:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALECTOR INC (ALEC:NASDAQ) since the previous trading day is $0.27.
ALECTOR INC (ALEC:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALECTOR INC (ALEC:NASDAQ) since the previous trading day is 14.7541%.
What is the most recent average sentiment score for ALECTOR INC (ALEC:NASDAQ)?
The most recent average sentiment score for ALECTOR INC (ALEC:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for ALECTOR INC (ALEC:NASDAQ)?
The most recent sentiment for ALECTOR INC (ALEC:NASDAQ) is .
SEC-8K** Filing Available For ALECTOR INC (ALEC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.